期刊文献+

胃癌患者凝血指标变化及临床意义 被引量:23

Changes and clinical significance of coagulation markers in patients with gastric cancer
下载PDF
导出
摘要 目的探讨胃癌患者凝血功能指标检测的变化及临床意义。方法采用CA7000全自动血凝分析仪测定128例胃癌患者的凝血酶原时间(PT)、部分凝血活酶时间(APTT)、纤维蛋白原(Fib)、凝血酶时间(TT)、D-二聚体(D-D)和抗凝血酶-Ⅲ(AT-Ⅲ),并与67例胃溃疡患者、84例胃炎患者及65例健康体检者进行比较。结果胃癌患者PT、APTT、TT较胃溃疡、胃炎患者和健康人明显延长(P<0.05),Fib、D-D明显增高(P<0.05),AT-Ⅲ则明显减低(P<0.05)。结论 PT、APTT、TT′结果延长,提示胃癌患者存在凝血功能紊乱;Fib、D-D结果增高可致胃癌患者血栓形成和癌细胞远处转移。因此,凝血功能指标监测对胃癌患者的治疗具有一定的指导意义。 Objective To explore the change and clinical significance of the coagulation function indexes in gastric cancer patients.Methods Using CA7000 fully-automatic blood coagulation analyzer,the prothrombin time(PT),activated partial thromboplastin time(APTT),thrombin time(TT),fibrinogen(Fib),D-dimer(D-D) and antithrombase-Ⅲ(AT-Ⅲ) were determined in 128 patients with gastric cancer,67 patients with peptic ulcer,84 patients with gastritis and 65 normal controls.Results PT,APTT and TT in the gastric cancer patients group were obviously extended than those in normal group(P0.05).And Fib and D-D were significantly higher than those in the normal group(P0.05).However,AT-Ⅲwas remarkably lower than that in the normal group(P0.05).Conclusion Prolongation of PT,APTT and TT reveals the disorder of coagulation function in the patients with gastric cancer.Fib and D-D increase could lead to thrombosis and distal metastasis of cancer cells.Therefore,monitoring the coagulation indexes has certain guidance significance to treatment of gastric cancer.
作者 张琳 唐沪强
出处 《检验医学与临床》 CAS 2012年第2期166-167,169,共3页 Laboratory Medicine and Clinic
关键词 胃癌 凝血功能 肿瘤转移 gastric cancer coagulation function neoplasm metastasis
  • 相关文献

参考文献10

  • 1Edwards RL,Rickles FR,Moritz TE,et al.Abnormalities of blood coagulation tests in patients with cancer[J].Am J Clin Pathol,1987,88(5):596-602.
  • 2李家增.止血异常与恶性肿瘤[J].血栓与止血学,2006,12(2):88-89. 被引量:29
  • 3林梅英,关莹.恶性肿瘤血液学改变机制[J].医学综述,2008,14(1):72-74. 被引量:16
  • 4Ikada M,Furukawa H,Imamura H,et al.Poor prognosis associated with thrombocytosis in patients with gastric cancer[J].Ann Surg Oncol,2002,9(3):287-291.
  • 5陈文慧,王辰.恶性肿瘤与血栓性疾病[J].中国医刊,2008,43(1):14-15. 被引量:22
  • 6Lugassy G,Fanlanga A,Kskksr A,et al.Thrombosis and cancer[M].London:Taylor & Francis,2004:117-127.
  • 7Mousa SA.Role of current and emerging antithrombotics in thrombosis and cancer[J].Drugs Today(Barc),2006,42(5):331-350.
  • 8魏文宁,郭涛,祝建芳,宋善俊.恶性肿瘤血栓前体蛋白水平改变的临床意义[J].中华内科杂志,2006,45(12):1026-1026. 被引量:12
  • 9Antonious D,Pavlakou G,Stathopoulos GP,et al.Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer[J].Lung Cancer,2006,53(2):205-211.
  • 10Rickles FR.Mechanisms of cancer-induced thrombosis in cancer[J].Pathophysiol Haemost Thromb,2006,35(1):103-110.

二级参考文献21

共引文献69

同被引文献189

引证文献23

二级引证文献144

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部